Dashboard Market News Pricing Contact Us
Search 100,000+ stocks...
English EN
Deutsch DE Español ES
Sign Up
Log in
Enanta Pharmaceuticals Inc banner

Enanta Pharmaceuticals Inc
NASDAQ:ENTA

Watchlist Manager
Enanta Pharmaceuticals Inc Logo
Enanta Pharmaceuticals Inc
NASDAQ:ENTA
Watchlist
Price: 12.96 USD 2.05% Market Closed
Market Cap: $376.9m
Write Note Create Alert Ask AI

Wall St Price Targets

ENTA Price Targets Summary
Enanta Pharmaceuticals Inc

Wall Street analysts forecast ENTA stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ENTA is 20.4 USD with a low forecast of 20.2 USD and a high forecast of 33.6 USD.

ENTA Lowest Forecast
Wall Street Target
$20.2
56% Upside
ENTA Average Forecast
Wall Street Target
$20.4
57% Upside
ENTA Highest Forecast
Wall Street Target
$33.6
159% Upside
Lowest Forecast
Price Target
20.2 USD
56% Upside
Average Forecast
Price Target
20.4 USD
57% Upside
Highest Forecast
Price Target
33.6 USD
159% Upside
Enanta Pharmaceuticals Inc Competitors:
Price Targets

Revenue
Forecast

4% / Year
Past Growth
24% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss
4% / Year
Past Growth
24% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Over the last 13 years, the compound annual growth rate for Revenue has been 4%. The projected CAGR for the next 8 years is 24%.

What are analyst estimates?

Gross Profit
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

What are analyst estimates?

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-2%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-2%
Average Miss

What are analyst estimates?

Pre-Tax Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-2%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-2%
Average Miss

What are analyst estimates?

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-2%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-2%
Average Miss

What are analyst estimates?

Continue ENTA Research

Summary
ENTA intrinsic value, competitors valuation, and company profile.
DCF Valuation
ENTA stock valuation using Discount Cash Flow valuation method.
Relative Valuation
ENTA stock valuation using valuation multiples.
Wall St Estimates
ENTA price targets and financial estimates made by Wall Street analysts.
Profitability
Detailed analysis of the company's profitability.
Solvency
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
ENTA stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall St Estimates
Profitability
Solvency
Financials
Discount Rate
Other Enanta Pharmaceuticals Inc listings:
F • EUR
9EP
 SWB • EUR
9EP
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is ENTA's stock price target?
Price Target
20.4 USD

According to Wall Street analysts, the average 1-year price target for ENTA is 20.4 USD with a low forecast of 20.2 USD and a high forecast of 33.6 USD.

What is the Revenue forecast for Enanta Pharmaceuticals Inc?
Projected CAGR
24%

Over the last 13 years, the compound annual growth rate for Revenue has been 4%. The projected CAGR for the next 8 years is 24%.

Back to Top
ALPHA SPREAD
Follow us
Join 357,600+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Valuation Backtest Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.